More than 70% of the global HA supply now comes from microbial fermentation, Future Market Insights reveals, as the skincare industry moves toward a preference for vegan and cruelty-free solutions. According to FMI’s research study, Bio-Fermented Hyaluronic Acid Market Forecast and Outlook, this market will surge from $63.7 million in 2025 to $189.5 million by 2035 [1].
Traditionally, hyaluronic acid has been sourced from animals, including roosters and cocks’ combs. However, challenges in managing animal tissues, high production costs, allergic reactions and ethical concerns surrounding animal-derived HA have driven the development of microbial production techniques. High-molecular-weight hyaluronic acid from Streptococcus is highly valued in medicine for its biocompatibility, while the lower-molecular-weight form from Bacillus is increasingly in demand in the growing cosmetic industry [2].
FMI notes that as BFHA find itself in care beyond traditional skincare, including dermal fillers, eye lubricants, tissue engineering, osteoarthritis and joint care and regenerative medicine, the powder form of the product is leading at 16.6%, due to longer shelf life, easier storage, high concentration and versatility across serums, creams and masks [1].
Asia-Pacific is emerging as the fastest-growing hub, according to FMI — fueled by its strong fermentation heritage, high consumer trust in bioactives, a booming premium skincare market and rising demand for dermocosmetic treatments [1].
"As consumers demand ingredients that are both ethically produced and clinically effective, fermentation-based HA is set to become a cornerstone of skincare and medical aesthetics over the next decade," said senior analysts at Future Market Insights.
References:
1- www.futuremarketinsights.com/reports/sample/rep-gb-29325
2-pmc.ncbi.nlm.nih.gov/articles/PMC10004376/
